E Tala
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 19
-
- Mycobacterium research and diagnosis 7
- Pneumocystis jirovecii pneumonia detection and treatment 3
-
- Electrolyte and hormonal disorders 4
-
- Immunodeficiency and Autoimmune Disorders 7
-
- Asthma and respiratory diseases 6
-
- Diagnosis and treatment of tuberculosis 5
-
- Hematological disorders and diagnostics 3
E Tala
59 papers receiving 801 citations
Peers
Comparison fields: 5 of 109
- Infectious Diseases 297
- Orthopedics and Sports Medicine 111
- Epidemiology 246
- Pulmonary and Respiratory Medicine 231
- Immunology 110
Countries citing papers authored by E Tala
This map shows the geographic impact of E Tala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Tala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Tala more than expected).
Fields of papers citing papers by E Tala
This network shows the impact of papers produced by E Tala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Tala. The network helps show where E Tala may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Tala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 12 | |
| 2 | 2000 | 33 | |
| 3 | 1998 | 52 | |
| 4 | 1998 | 41 | |
| 5 | 1994 | 49 | |
| 6 | 1994 | 80 | |
| 7 | 1994 | 15 | |
| 8 | 1994 | 63 | |
| 9 | 1994 | 4 | |
| 10 | 1993 | 45 | |
| 11 | 1992 | 39 | |
| 12 | 1992 | 2 | |
| 13 | 1992 | 3 | |
| 14 | 1992 | 16 | |
| 15 | 1991 | 65 | |
| 16 | [Tuberculosis in Scandinavia--Finland families' black sheep]. | 1990 | 1 |
| 17 | 1990 | 1 | |
| 18 | Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin. | 1969 | 6 |
| 19 | Carcinoma of the lung. A retrospective study with special reference to pre-diagnosis period and roentgenographic signs. | 1967 | 15 |
| 20 | On the changes of the free 17-hydroxycorticosteroid content in plasma during extracorporeal circulation. | 1961 | 1 |
About E Tala
E Tala is a scholar working on Infectious Diseases, Behavioral Neuroscience, Pulmonary and Respiratory Medicine, Emergency Medicine and Biological Psychiatry, having authored 61 papers that have together received 884 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Asthma and respiratory diseases (6 papers), Diagnosis and treatment of tuberculosis (5 papers), Electrolyte and hormonal disorders (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Infectious Diseases (297 citations), Orthopedics and Sports Medicine (111 citations), Epidemiology (246 citations), Pulmonary and Respiratory Medicine (231 citations) and Immunology (110 citations). E Tala has collaborated with scholars based in Finland, United Kingdom and United States. Frequent co-authors include Kari Liippo, Hannu Puolijoki, Jaakko Herrala, E Huhti, Raimo Isoaho, Matti K. Viljanen, Mikael Skurnik, Olli Impivaara, Juhani Tuominen and Hanna Soini. Their work appears in journals such as Bone, Scandinavian Journal of Rheumatology, European Journal of Endocrinology, Biochemical Pharmacology and Infection Control and Hospital Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.